【4598】Delta-Fly Pharma

創薬。抗がん剤。

東証グロース

医薬品医薬

＞

新薬メーカー新薬

業績予想修正履歴

{{models[key].tabname}}

決算期	日付	予・実	売上高 (百万円)	対前回	修正率	修正率	営業利益 (百万円)	対前回	修正率	修正率	経常利益 (百万円)	対前回	修正率	修正率	当期利益 (百万円)	対前回	修正率	修正率
2024.03	2024/02/13	Q3予	-	-	-	-	-1,312	→	0.0%	0.0%	-1,320	→	0.0%	0.0%	-1,323	→	0.0%	0.0%
2024.03	2023/11/13	Q2予	-	-	-	-	-1,312	→	0.0%	0.0%	-1,320	→	0.0%	0.0%	-1,323	→	0.0%	0.0%
2024.03	2023/08/14	Q1予	-	-	-	-	-1,312	→	0.0%	0.0%	-1,320	→	0.0%	0.0%	-1,323	→	0.0%	0.0%
2024.03	2023/05/15	当初予	-	-	-	-	-1,312	-	-	-	-1,320	-	-	-	-1,323	-	-	-
2023.03	2023/05/15	実	0	↓	-100.0%	-100.0%	-1,315	→	0.0%	-14.3%	-1,325	→	0.0%	-15.2%	-1,328	→	0.0%	-15.5%
2023.03	2023/04/21	修正予	-	-	-	-	-1,315	↓	-14.3%	-14.3%	-1,325	↓	-15.2%	-15.2%	-1,328	↓	-15.5%	-15.5%
2023.03	2023/02/14	Q3予	300	→	0.0%	0.0%	-1,150	→	0.0%	0.0%	-1,150	→	0.0%	0.0%	-1,150	→	0.0%	0.0%
2023.03	2022/11/14	Q2予	300	→	0.0%	0.0%	-1,150	→	0.0%	0.0%	-1,150	→	0.0%	0.0%	-1,150	→	0.0%	0.0%
2023.03	2022/08/12	Q1予	300	→	0.0%	0.0%	-1,150	→	0.0%	0.0%	-1,150	→	0.0%	0.0%	-1,150	→	0.0%	0.0%
2023.03	2022/05/13	当初予	300	-	-	-	-1,150	-	-	-	-1,150	-	-	-	-1,150	-	-	-
2022.03	2022/05/13	実	300	→	0.0%	+200.0%	-961	↑	+12.6%	+26.1%	-964	↑	+12.4%	+25.8%	-967	↑	+12.1%	+25.6%
2022.03	2022/03/08	修正予	300	↑	+200.0%	+200.0%	-1,100	↑	+15.4%	+15.4%	-1,100	↑	+15.4%	+15.4%	-1,100	↑	+15.4%	+15.4%
2022.03	2022/02/14	Q3予	100	→	0.0%	0.0%	-1,300	→	0.0%	0.0%	-1,300	→	0.0%	0.0%	-1,300	→	0.0%	0.0%
2022.03	2021/11/11	Q2予	100	→	0.0%	0.0%	-1,300	→	0.0%	0.0%	-1,300	→	0.0%	0.0%	-1,300	→	0.0%	0.0%
2022.03	2021/08/13	Q1予	100	→	0.0%	0.0%	-1,300	→	0.0%	0.0%	-1,300	→	0.0%	0.0%	-1,300	→	0.0%	0.0%
2022.03	2021/05/14	当初予	100	-	-	-	-1,300	-	-	-	-1,300	-	-	-	-1,300	-	-	-
2021.03	2021/05/14	実	300	→	0.0%	0.0%	-852	↓	-0.2%	-0.2%	-859	↓	-1.1%	-1.1%	-862	↓	-1.4%	-1.4%
2021.03	2021/02/12	Q3予	300	→	0.0%	0.0%	-850	→	0.0%	0.0%	-850	→	0.0%	0.0%	-850	→	0.0%	0.0%
2021.03	2020/11/12	Q2予	300	→	0.0%	0.0%	-850	→	0.0%	0.0%	-850	→	0.0%	0.0%	-850	→	0.0%	0.0%
2021.03	2020/08/14	Q1予	300	→	0.0%	0.0%	-850	→	0.0%	0.0%	-850	→	0.0%	0.0%	-850	→	0.0%	0.0%
2021.03	2020/05/14	当初予	300	-	-	-	-850	-	-	-	-850	-	-	-	-850	-	-	-
2020.03	2020/05/14	実	100	→	0.0%	0.0%	-1,545	↓	-1.6%	-44.9%	-1,552	↓	-1.6%	-45.6%	-1,555	↓	-1.6%	-45.5%
2020.03	2020/03/24	修正予	100	-	-	-	-1,520	↓	-42.6%	-42.6%	-1,527	↓	-43.2%	-43.2%	-1,531	↓	-43.2%	-43.2%
2020.03	2020/02/14	Q3予	-	-	-	-	-1,066	→	0.0%	0.0%	-1,066	→	0.0%	0.0%	-1,069	→	0.0%	0.0%
2020.03	2019/11/14	Q2予	-	-	-	-	-1,066	→	0.0%	0.0%	-1,066	→	0.0%	0.0%	-1,069	→	0.0%	0.0%
2020.03	2019/08/14	Q1予	-	-	-	-	-1,066	→	0.0%	0.0%	-1,066	→	0.0%	0.0%	-1,069	→	0.0%	0.0%
2020.03	2019/05/15	当初予	-	-	-	-	-1,066	-	-	-	-1,066	-	-	-	-1,069	-	-	-
2019.03	2019/05/15	実	0	→	-	-100.0%	-592	↑	+13.2%	+13.2%	-671	↓	-2.6%	+9.2%	-673	↓	-2.4%	+9.2%
2019.03	2019/03/26	修正予	0	↓	-100.0%	-100.0%	-	-	-	-	-654	↑	+11.5%	+11.5%	-657	↑	+11.3%	+11.3%
2019.03	2019/02/14	Q3予	200	→	0.0%	0.0%	-682	→	0.0%	0.0%	-739	→	0.0%	0.0%	-741	→	0.0%	0.0%
2019.03	2018/11/14	当初予	200	-	-	-	-682	-	-	-	-739	-	-	-	-741	-	-	-

【4598】Delta-Fly Pharma 創薬。抗がん剤。

業績予想修正履歴

【4598】Delta-Fly Pharma

創薬。抗がん剤。